SNDX · Syndax Pharmaceuticals Inc · Share Buybacks
$8.72
-0.41 (-4.49%)
At close · Nov 20
Return incl. dividend (before tax)
Play latest call
Q2 2026 earnings call transcript
Market Cap
$778.67M
Shares
89.30M
Volume · Nov 20
2.18M
Avg daily vol (3M)
2.61M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
7,200,000 shares
as of 2026-01-01
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2023-05 | — | $200,000,000 | $157,900,000 as of 2026-09-30 | — | 10-Q , filed 2026-11-02 |
Key facts
CIK
1395937
CUSIP
87164F105
13F (30d)
241 filings
222 filers
Visit website
Investor relations